IMVT - Immunovant announces proposed offering of $300M of common stock
2023-09-26 17:13:07 ET
More on Immunovant
- Seeking Alpha’s Quant Rating on Immunovant
- Historical earnings data for Immunovant
- Financial information for Immunovant
- Immunovant: Data Sizzles, But The Steak Isn't Done Yet (Rating Upgrade)
- Immunovant, Inc. 2023 Q2 - Results - Earnings Call Presentation
- Immunovant Stock: With Anti-FcRn Validation Continuing, This Is A Must-Watch
- Biggest stock movers today: Sirius XM, United Natural Foods, Immunovant and more
- Immunovant climbs 102% on Phase 1 data for autoimmune drug (updated)
- Immunovant stock jumps on positive data for Argenx drug (update)
For further details see:
Immunovant announces proposed offering of $300M of common stock